Figure 1From: Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunctionEthanolamine plasmalogen levels in 158JP oligodendrocytes and Pelizaeus- Merzbacher disease (PMD) fibroblasts and lymphocytes. N = 6. *, p < 0.01 vs. control. Mean ± SEM.Back to article page